This $601,075 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) aims to evaluate factors contributing to delays in diagnosing peripartum cardiomyopathy (PPCM), particularly among Black women. The primary objectives are to determine patient, provider, and health system factors driving delayed PPCM diagnosis, and to develop a feasible intervention to improve timely diagnosis and reduce related disparities.
The Trustees of the University of Pennsylvania, doing business as Clinical Practices of the University of Pennsylvania, will conduct this mixed-methods study over a 5-year period starting January 1, 2025. Key activities include in-depth patient interviews, provider surveys, and stakeholder engagement to inform the development and pilot testing of the intervention at five clinical sites. This work has the potential to improve short- and long-term maternal cardiovascular outcomes and may inform approaches to address diagnosis delays for other cardiovascular conditions in women.
Generated 2/25/25, 5:19 AM